These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

631 related articles for article (PubMed ID: 21902293)

  • 1. Triple antiplatelet therapy in acute coronary syndromes.
    Valgimigli M; Minarelli M
    Drugs; 2011 Sep; 71(13):1703-19. PubMed ID: 21902293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: glycoprotein IIb/IIIa inhibitors, clopidogrel, or both?
    Silva MA; Donovan JL; Gandhi PJ; Volturo GA
    Vasc Health Risk Manag; 2006; 2(1):39-48. PubMed ID: 17319468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet intervention in acute coronary syndrome.
    Arora RR; Rai F
    Am J Ther; 2009; 16(5):e29-40. PubMed ID: 19092648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The emerging role of platelet glycoprotein IIb/IIIa inhibitors in managing high-risk patients with non-ST segment elevation acute coronary syndromes.
    Bolognese L
    Curr Med Res Opin; 2007 Jun; 23(6):1217-26. PubMed ID: 17559721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evidence-based management of ST-segment elevation myocardial infarction (STEMI). Latest guidelines of the European Society of Cardiology (ESC) 2010].
    Silber S
    Herz; 2010 Dec; 35(8):558-64. PubMed ID: 21107514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost Effectiveness of Antiplatelet and Antithrombotic Therapy in the Setting of Acute Coronary Syndrome: Current Perspective and Literature Review.
    Fanari Z; Weiss S; Weintraub WS
    Am J Cardiovasc Drugs; 2015 Dec; 15(6):415-27. PubMed ID: 26068886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet inhibition by abciximab bolus-only administration and oral ADP receptor antagonist loading in acute coronary syndrome patients: the blocking and bridging strategy.
    Christ G; Hafner T; Siller-Matula JM; Francesconi M; Grohs K; Wilhelm E; Podczeck-Schweighofer A
    Thromb Res; 2013 Jul; 132(1):e36-41. PubMed ID: 23791395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managing acute coronary syndrome: evidence-based approaches.
    Spinler SA
    Am J Health Syst Pharm; 2007 Jun; 64(11 Suppl 7):S14-24. PubMed ID: 17519441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiplatelet therapy in acute coronary syndromes.
    Barker CM; Price MJ
    Curr Cardiol Rep; 2008 Jul; 10(4):327-33. PubMed ID: 18611368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplatelet strategies: evaluating their current role in the setting of acute coronary syndromes.
    Braunwald E; Angiolillo D; Bates E; Berger PB; Bhatt D; Cannon CP; Furman MI; Gurbel P; Michelson AD; Peterson E; Wiviott S
    Clin Cardiol; 2008 Mar; 31(3 Suppl 1):I2-9. PubMed ID: 18481818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triple antiplatelet therapy for preventing vascular events: a systematic review and meta-analysis.
    Geeganage C; Wilcox R; Bath PM
    BMC Med; 2010 Jun; 8():36. PubMed ID: 20553581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current patterns of antithrombotic and revascularisation therapy in patients hospitalised for acute coronary syndromes. Data from the Polish subset of the EPICOR study.
    Wojtkowska I; Stępińska J; Stępień-Wojno M; Sobota M; Kopaczewski J; Reszka Z; Kurzelewski M; Medina J
    Kardiol Pol; 2017; 75(5):445-452. PubMed ID: 28281731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
    Harrington RA; Becker RC; Cannon CP; Gutterman D; Lincoff AM; Popma JJ; Steg G; Guyatt GH; Goodman SG
    Chest; 2008 Jun; 133(6 Suppl):670S-707S. PubMed ID: 18574276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of IIb/IIIa inhibitors in combination with highly active oral antiplatelet regimens in acute coronary syndromes: A meta-analysis of pivotal trials.
    Roule V; Agueznai M; Sabatier R; Blanchart K; Lemaître A; Ardouin P; Collet JP; Milliez P; Montalescot G; Beygui F
    Platelets; 2017 Mar; 28(2):174-181. PubMed ID: 27657930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The clinical use of the GPIIb/IIIa inhibitors eptifibatide and tirofiban in the treatment of acute coronary syndromes of the "non-ST elevation" type].
    Galli M; Maggioni AP; Vassanelli C; Tavazzi L
    Ital Heart J Suppl; 2000 Feb; 1(2):202-11. PubMed ID: 10731377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of platelet glycoprotein IIb/IIIa inhibitors in diabetics undergoing PCI for non-ST-segment elevation acute coronary syndromes: impact of clinical status and procedural characteristics.
    Bauer T; Möllmann H; Weidinger F; Zeymer U; Seabra-Gomes R; Eberli F; Serruys P; Vahanian A; Silber S; Wijns W; Hochadel M; Nef HM; Hamm CW; Marco J; Gitt AK
    Clin Res Cardiol; 2010 Jun; 99(6):375-83. PubMed ID: 20186546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug therapy during percutaneous coronary interventions in stable and unstable coronary artery disease: the Italian Drug Evaluation in Angioplasty (IDEA) study.
    Savonitto S; Ambrosini V; Marzocchi A; Tolaro S; Petronio AS; Galassi AR; Bongo AS; Gaglione A; Bolognese L; ;
    Ital Heart J; 2005 Feb; 6(2):106-18. PubMed ID: 15819503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eptifibatide provides additional platelet inhibition in non-ST-elevation myocardial infarction patients already treated with aspirin and clopidogrel. Results of the platelet activity extinction in non-Q-wave myocardial infarction with aspirin, clopidogrel, and eptifibatide (PEACE) study.
    Dalby M; Montalescot G; Bal dit Sollier C; Vicaut E; Soulat T; Collet JP; Choussat R; Gallois V; Drobinski G; Drouet L; Thomas D
    J Am Coll Cardiol; 2004 Jan; 43(2):162-8. PubMed ID: 14736431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of platelet surface receptors and early changes in platelet function in patients with STEMI treated with abciximab and clopidogrel versus clopidogrel alone.
    Konopka A; Spychalska J; Sitkiewicz D; Zdebska E; Pilichowska I; Piotrowski W; Stepińska J
    Am J Cardiovasc Drugs; 2007; 7(6):433-9. PubMed ID: 18076210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approach to non-ST-segment elevation acute coronary syndrome in the emergency department: risk stratification and treatment strategies.
    Lefebvre CW; Hoekstra J
    Hosp Pract (1995); 2010 Apr; 38(2):40-9. PubMed ID: 20469612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.